MenACWY risk groups: patient group direction template
Patient group direction (PGD) template to support the provision of MenACWY vaccine to individuals with underlying medical conditions.
Applies to England
Documents
Details
This PGD template supports the provision of additional meningococcal group A, C, W and Y (MenACWY) conjugate vaccine to individuals with underlying medical conditions.
MenACWY at risk groups PGD version 4.00 is valid from 28 February 2023 to 28 February 2025. Pending changes to the childhood immunisation schedule which impact upon the contents of this PGD, the validity of version 4.0 has been extended by a further 6 months to 31 August 2025.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see ). Practitioners should follow local policy and procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and for the vaccine.
Updates to this page
-
Added notice of extension.
-
Added version 04.00, see page 2 for changes.
-
Added updated PGD: v3.00.
-
Added version V04.00 - routine review of PGD prior to expiry and removal of black triangle status for Nimenrix.
-
First published.